Showing results (131-140 of 230) with videos related to
Sort By:
Pageof 23
Journal of Abnormal Psychology|March 13, 2018
Dimensions of deprivation and threat, psychopathology, and potential mediators: A multi-year longitudinal analysisAdam Bryant Miller, Margaret A Sheridan, Jamie L Hanson, et al.Clinical Psychological Science : a Journal of the Association for Psychological Science|March 24, 2021
Low Emotional Awareness as a Transdiagnostic Mechanism Underlying Psychopathology in AdolescenceDavid G Weissman, Erik C Nook, Aridenne A Dews, et al.Expert Opinion on Drug Delivery|April 13, 2026
Review of the first on-body injector (obi) for the subcutaneous delivery of an oncology drug: isatuximab in multiple myelomaEnrique M Ocio, Gurdeep Parmar, María-Victoria Mateos, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
In vivo tracking of dendritic cells in patients with multiple myelomaH Miles Prince, Dominic M Wall, David Ritchie, et al.American Journal of Hematology|February 6, 2015
The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefitSimon J Harrison, Hang Quach, Emma Link, et al.BMC Psychiatry|March 19, 2022
Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorderTory Eisenlohr-Moul, Madeline Divine, Katja Schmalenberger, et al.World Neurosurgery|January 14, 2020
Intraoperative Shoulder Traction as Cause of C5 Palsy: Magnetic Resonance Imaging StudyRoyce W Woodroffe, Logan C Helland, Adam Bryant, et al.Blood Advances|May 20, 2022
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myelomaThomas Martin, Joseph Mikhael, Roman Hajek, et al.Annals of Hematology|August 9, 2022
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomesXavier Leleu, Thomas Martin, Katja Weisel, et al.Internal Medicine Journal|January 8, 2026
Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupShirlene Sim, Georgia McCaughan, Andrew Zannettino, et al.Pageof 23